comprehensive -WSS

comprehensive

author：fashion 2025-09-06 02:11:09 - browse：36

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How Long Island became the ‘eugenics capital of the world’

WSS

AstraZeneca bets AAV gene therapy will still deliver the goods

How to make Best Hospitals ratings actually useful for patients

Apellis safety probe of eye disease drug centers on injection needle

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Appeals court upholds limits to abortion pill

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

entertainment

comprehensive

Sign up for D.C. Diagnosis

hotspot

Bright Health sells Medicare Advantage business to Molina

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Activists slam private health insurers over coverage restrictions

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Bright Health sells Medicare Advantage business to Molina

Federal judge rules Oregon’s tough new gun law is constitutional

Medicare proposal to cover medical devices draws a mixed reaction

In science, is the line between industry and academia shifting?

BioMarin wins approval for gene therapy to treat hemophilia A

AstraZeneca bets AAV gene therapy will still deliver the goods

focus

Why police arrested suspected Gilgo Beach killer away from his house

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Psilocybin's anti

As pharma fights Medicare drug negotiation, hospitals, docs silent

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

2024 GOP presidential candidates spar over abortion in debate

focus

focus

explore

entertainment